Tiger Eye Capital’s Thermo Fisher Scientific TMO Stock Holding History

Tiger Eye Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-361	Closed	-$213K	–	49
2022 Q1	$213K	Sell	361 -5,913	-94%	-$3.4M	0.08%	50
2021 Q4	$4.19M	Buy	6,274 +5,850	+1,380%	+$3.65M	1.15%	16
2021 Q3	$242K	Hold	424	–	–	0.09%	47
2021 Q2	$214K	Buy	+424	New	+$200K	0.05%	54
2021 Q1	–	Sell	-5,271	Closed	-$2.46M	–	72
2020 Q4	$2.46M	Buy	5,271 +4,469	+557%	+$2.1M	0.43%	29
2020 Q3	$354K	Sell	802 -6,537	-89%	-$2.7M	0.09%	34
2020 Q2	$2.66M	Buy	+7,339	New	+$2.46M	0.63%	19
2019 Q3	–	Sell	-1,220	Closed	-$358K	–	41
2019 Q2	$358K	Sell	1,220 -63,721	-98%	-$17.6M	0.07%	40
2019 Q1	$17.8M	Buy	+64,941	New	+$16.2M	4.32%	6
2015 Q3	–	Sell	-70,100	Closed	-$9.1M	–	49
2015 Q2	$9.1M	Buy	+70,100	New	+$9.14M	0.67%	38

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tiger Eye Capital's TMO Position: Q2 2022 in Review

Tiger Eye Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 361 shares — an estimated $213K sold.

Tiger Eye Capital first reported a position in TMO in Q2 2015 and held it in 10 quarters. The position peaked at $17.8M in Q1 2019. 2,282 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Tiger Eye Capital reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
Tiger Eye Capital sold 361 Thermo Fisher Scientific shares in Q2 2022, an estimated $213K.
Tiger Eye Capital first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 10 quarters.
Tiger Eye Capital's Thermo Fisher Scientific position peaked at $17.8M in Q1 2019.
2,282 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Tiger Eye Capital's 13F filing for Q2 2022, filed 15 Aug 2022.